MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA

Author:

Barry, MD M.1,Roehrborn, MD C.2

Affiliation:

1. General Medicine Division, Medical Services, Massachusetts General Hospital, 50 Staniford Street—9th Floor, Boston, Massachusetts 02114;

2. Division of Urology, Department of Surgery, Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, Texas 75235-9110;

Abstract

▪ Abstract  Benign prostatic hyperplasia (BPH) is a common cause of morbidity among older men. Primary care physicians need to develop expertise in its management. The causes of BPH are unknown; aging and the presence of male androgens are the dominant risk factors. Obtaining a medical history is a key step in assessing whether lower urinary tract symptoms are due to BPH or to some other process. A reliable and valid seven-item questionnaire has been developed to objectively assess symptom severity. A focused physical examination including a digital rectal exam should be performed, as well as a urinalysis and serum creatinine. Optional tests include uroflowmetry, post-void residual urine, and prostate-specific antigen measurements. BPH is treated primarily to improve the quality, rather than increase the quantity, of life. Optimal decisions about treatment are best made by a clinician and an informed patient working together.

Publisher

Annual Reviews

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Prostate diseases;Pathy's Principles and Practice of Geriatric Medicine;2022-02-18

2. 3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5α-reductase inhibitors;Medicinal Chemistry Research;2012-03-17

3. Prostate Diseases;Pathy's Principles and Practice of Geriatric Medicine;2012-03-12

4. A Review on Various Analytical Methods on Some Alpha Adrenergic Antagonists;Current Pharmaceutical Analysis;2011-02-01

5. Ethanol extracts of saw palmetto contain the indirectly acting sympathomimetic: Tyramine;The Prostate;2010-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3